Recent advances in next-generation sequencing and bioinformatics have enabled the identification of mRNA expression profiles that are unique to different types of cancers. These mRNA signatures can be used to diagnose cancer more accurately and to identify the specific subtype of the disease. Techniques such as quantitative PCR and microarrays are commonly used to measure mRNA levels in clinical samples.
